Skip to main content
. 2013 Dec 18;34(3):393–399. doi: 10.1007/s00296-013-2921-y

Fig. 1.

Fig. 1

TSA concentrations in patients with rheumatic diseases. C controls, RA rheumatoid arthritis, SSc systemic sclerosis, SLE systemic lupus erythematosus